Clinical trial
Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
NCT04883840 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- October 22, 2020
- Completion date
- October 11, 2025
- Enrollment
- 177 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis